Pharmaceutical company Race Oncology
(ASX:RAC) has been invited to present at the Biotec Showcase at the JP Morgan Healthcare Conference in San Francisco next week for the first time.
Race Oncology Chief Executive Peter Molloy will present on the opening day of the conference.
He said the conference is the largest and most informative healthcare investment symposiums on the US investment calendar and will help to build the company’s international profile.
He added that it is a pivotal opportunity to present the company’s key chemotherapy drug Bisantrene and share the company’s investment story to more than eight thousand attendees from all over the world.
The company has spent the previous months meeting with potential investors in New York and London who have an interest in ASX-listed companies.
Shares in Race Oncology
(ASX:RAC) are trading 3 per cent lower to 46 cents.
